Related Experiment Video
Updated: Mar 22, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Mitochondrial Dysfunction during the Early Stages of Excitotoxic Spinal Motor Neuron Degeneration in Vivo
Luz Diana Santa-Cruz1, Sergio Guerrero-Castillo1, Salvador Uribe-Carvajal1
1División de Neurociencias and División de Investigación Básica, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México , 04510 México, D.F., México.
Abstract:
Glutamate excitotoxicity and mitochondrial dysfunction are involved in motor neuron degeneration process during amyotrophic lateral sclerosis (ALS). We have previously shown that microdialysis perfusion of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) in the lumbar region of the rat spinal cord produces permanent paralysis of the ipsilateral hindlimb and death of motor neurons by a Ca(2+)-dependent mechanism, in a process that starts 2-3 h after AMPA perfusion. Co-perfusion with different energy metabolic substrates, mainly pyruvate, prevented the paralysis and motor neuron degeneration induced by AMPA, suggesting that mitochondrial energetic deficiencies are involved in this excitotoxic motor neuron death. To test this, in the present work, we studied the functional and ultrastructural characteristics of mitochondria isolated from the ventral horns of lumbar spinal cords of rats, at the beginning of the AMPA-induced degeneration process, when motor neurons are still alive. Animals were divided in four groups: perfused with AMPA, AMPA + pyruvate, and pyruvate alone and Krebs-Ringer medium as controls. Mitochondria from the AMPA-treated group showed decreased oxygen consumption rates, respiratory controls, and transmembrane potentials. Additionally, activities of the respiratory chain complexes I and IV were significantly decreased. Electron microscopy showed that mitochondria from AMPA-treated rats presented swelling, disorganized cristae and disrupted membranes. Remarkably, in the animals co-perfused with AMPA and pyruvate all these abnormalities were prevented. We conclude that mitochondrial dysfunction plays a crucial role in spinal motor neuron degeneration induced by overactivation of AMPA receptors in vivo. These mechanisms could be involved in ALS motor neuron degeneration.
Insights
Mitochondrial dysfunction contributes to motor neuron death in amyotrophic lateral sclerosis (ALS). Pyruvate protects against α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) induced motor neuron damage by preventing mitochondrial impairment.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Glutamate excitotoxicity and mitochondrial dysfunction are implicated in amyotrophic lateral sclerosis (ALS) motor neuron degeneration.
- Previous studies demonstrated that α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) perfusion causes motor neuron death via a Ca(2+)-dependent mechanism.
Purpose of the Study:
- To investigate the role of mitochondrial dysfunction in AMPA-induced motor neuron degeneration.
- To examine the protective effects of pyruvate on mitochondrial function during excitotoxic injury.
Main Methods:
- Isolated mitochondria from rat spinal cords after AMPA perfusion with or without pyruvate.
- Assessed mitochondrial function via oxygen consumption, respiratory control, and transmembrane potential measurements.
- Analyzed respiratory chain complex activities and mitochondrial ultrastructure using electron microscopy.
Main Results:
- AMPA perfusion led to decreased mitochondrial oxygen consumption, respiratory control, and transmembrane potential.
- Activities of respiratory chain complexes I and IV were significantly reduced in AMPA-treated rats.
- Electron microscopy revealed mitochondrial swelling, disorganized cristae, and membrane disruption, which were prevented by pyruvate co-perfusion.
Conclusions:
- Mitochondrial dysfunction is a critical factor in spinal motor neuron degeneration caused by AMPA receptor overactivation in vivo.
- These findings suggest that targeting mitochondrial dysfunction may offer therapeutic strategies for ALS.
More Related Videos
07:43Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020